Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Erica Decker
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0000-0002-7122-1447
Observed ORCID:
0000-0002-7122-1447
OpenAlex ID:
A5081813240
Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ ‐1a Biologics
2022
·
Paula L. Hyland
, Lakshmi Manasa S. Chekka
, et al.
·
Clinical Pharmacology & Therapeutics
·
13
Characterization of Proteomic Pharmacodynamic Biomarkers of IFNβ ‐1a Biologics to Inform Potential Utility in Biosimilar Development
2025
·
Lakshmi Manasa S. Chekka
, Deepti P. Samarth
, et al.
·
Clinical Pharmacology & Therapeutics
·
4
Evaluating miRNA Sequencing and Integrative Proteomics for Identifying Plasma miRNAs as Potential Pharmacodynamic Biomarkers of IFNβ ‐1a Biologics
2025
·
Mai Mehanna
, Lakshmi Manasa Chekka
, et al.
·
Clinical and Translational Science
·
1
PDF
Proteomic Identification of Plasma Biomarkers of Response to IL‐5 Inhibitor Biologics in Healthy Subjects
2025
·
Lakshmi Manasa S. Chekka
, Deepti P. Samarth
, et al.
·
Clinical and Translational Science
·
1
PDF
Show more works
View as search
Works count:
4
Citation count:
19
H-index:
2
I10-index:
1
Year
Topic
Type